Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New study seeks best pain block for lung surgery recovery

NCT ID NCT07467291

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 11, 2026 · Updated 4 times

Summary

This study compares two types of nerve blocks (SPSIP block and SAP block) to manage pain after video-assisted lung surgery (VATS). About 70 adults aged 18-65 will receive one of the two blocks before surgery. The goal is to see which block provides better pain relief and helps patients recover faster.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jan 2026

Finished

Aug 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 65 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * aged 18-65 years, * with American Society of Anesthesiologists (ASA) physical status classification I-III, * Body Mass Index (BMI) \< 35 kg/m², * and who read and signed the informed consent form were included. Exclusion Criteria: * inability to communicate in Turkish, refusal to consent, * inability to use the numerical pain rating scale (NRS), * allergy to local anesthetics or study-specific analgesics; * pregnancy or breastfeeding; * uncontrolled anxiety or substance dependence; * history of thoracic surgery, * trauma, * neuromuscular or peripheral nerve disorders; * diabetes mellitus, * hepatic or renal insufficiency, * coagulation disorders; * chronic opioid or steroid use; * widespread pain; * anticoagulant therapy; * infection at the block application site; * early termination of surgery; * absence of planned postoperative extubation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Applying sap block with ultrasound guidance after vats are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Fırat University Faculty of Medicine Hospital

    Elâzığ, 23100, Turkey (Türkiye)